Hepatoblastoma Overview

Save information for later
Sign Up

Learn About Hepatoblastoma

What is the definition of Hepatoblastoma?
Hepatoblastoma is a rare malignant (cancerous) tumor of the live, usually affecting young children. In early stages of the condition, there may be no concerning signs or symptoms. As the tumor gets larger, affected children may experience a painful, abdominal lump; swelling of the abdomen; unexplained weight loss; loss of appetite; and/or nausea and vomiting. The exact underlying cause of Hepatoblastoma is poorly understood. Risk factors for the tumor include prematurity with a very low birth weight, early exposure to hepatitis B infection, biliary atresia, and several different genetic conditions (i.e. Beckwith-Wiedemann syndrome, familial adenomatous polyposis, Aicardi syndrome, Glycogen storage disease, and Simpson-Golabi-Behmel syndrome).
What are the alternative names for Hepatoblastoma?
  • Hepatoblastoma
Who are the top Hepatoblastoma Local Doctors?
Dr. Saeeda Z. Chowdhury
Hematology Oncology | Hematology | Oncology
Dr. Saeeda Z. Chowdhury
Hematology Oncology | Hematology | Oncology

Prisma Health University Medical Group

65 International Dr, 
Greenville, SC 
 187.7 mi
Accepting New Patients
Offers Telehealth
Languages Spoken English

Saeeda Chowdhury is a Hematologist Oncology specialist and a Hematologist in Greenville, South Carolina. Dr. Chowdhury and is rated as an Advanced provider by MediFind in the treatment of Hepatoblastoma. Her top areas of expertise are Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Chowdhury is currently accepting new patients.

Dr. Jacqueline M. Kraveka
Pediatric Hematology Oncology | Pediatrics
Dr. Jacqueline M. Kraveka
Pediatric Hematology Oncology | Pediatrics

University Medical Associates Of The Medical University Of South Carol

171 Ashley Ave, 
Charleston, SC 
 10.5 mi
Accepting New Patients
Offers Telehealth
Languages Spoken English

Jacqueline Kraveka is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in Charleston, South Carolina. Dr. Kraveka and is rated as an Experienced provider by MediFind in the treatment of Hepatoblastoma. Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Aspiration. Dr. Kraveka is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Stuart Cramer
Pediatric Hematology Oncology | Pediatrics | Hematology
Dr. Stuart Cramer
Pediatric Hematology Oncology | Pediatrics | Hematology

Prisma Health Medical Group-Midlands

7 Richland Medical Park Dr, 
Columbia, SC 
 96.4 mi
Languages Spoken English

Stuart Cramer is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in Columbia, South Carolina. Dr. Cramer and is rated as an Advanced provider by MediFind in the treatment of Hepatoblastoma. His top areas of expertise are Hepatoblastoma, Adult Soft Tissue Sarcoma, Ependymoma, Rhabdomyosarcoma, and Bone Marrow Aspiration.

View All Doctors
What are the latest Hepatoblastoma Clinical Trials?
A Multi-Center Phase I Study of Codrituzumab in Pediatric Patients With Relapsed or Refractory Glypican 3 (GPC3) Expressing Extra-cranial Solid Tumors
A Multi-Center Phase I Study of Codrituzumab in Pediatric Patients With Relapsed or Refractory Glypican 3 (GPC3) Expressing Extra-cranial Solid Tumors
Enrollment Status: Recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Phase: Phase 1

Summary: The purpose of this study to find out whether codrituzumab is a safe treatment that causes few or mild side effects in children and young adults who have solid tumors that express the protein GPC3. The researchers also want to study the way codrituzumab is absorbed, distributed, and cleared from the body.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Hepatic Tumors Research Consortium Initiative
Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Hepatic Tumors Research Consortium Initiative
Enrollment Status: Recruiting
Publish Date: December 12, 2024
Intervention Type: Other

Summary: There are limited data regarding the biology and treatment of relapsed/refractory hepatoblastoma (rrHBL). This project provides the infrastructure for acquisition of biological specimens, imaging, and correlative clinical data to facilitate biology studies and characterization of rrHBL. This registry will collect clinical, demographic, and pathological data, specimens (as available) and imaging fr...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center